Ligand profile
6O2
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02344 — moeB family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
6O2- PDB
5l6h- UniProt (similar protein)
P22515- Target protein
- KP13_02344
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 174.7
- −1 ≤ LogP ≤ 5 -0.61
- MW ≤ 500 Da 446.4
- LogP ≤ 5 -0.61
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 174.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C#Cc1cccc(c1)Nc2c3c(ncn2)n(cn3)C4C(C(C(O4)COS(=O)(=O)N)O)OC#Cc1cccc(c1)Nc2c3c(ncn2)n(cn3)C4C(C(C(O4)COS(=O)(=O)N)O)O
InChI=1S/C18H18N6O6S/c1-2-10-4-3-5-11(6-10)23-16-13-17(21-8-20-16)24(9-22-13)18-15(26)14(25)12(30-18)7-29-31(19,27)28/h1,3-6,8-9,12,14-15,18,25-26H,7H2,(H2,19,27,28)(H,20,21,23)InChI=1S/C18H18N6O6S/c1-2-10-4-3-5-11(6-10)23-16-13-17(21-8-20-16)24(9-22-13)18-15(26)14(25)12(30-18)7-29-31(19,27)28/h1,3-6,8-9,12,14-15,18,25-26H,7H2,(H2,19,27,28)(H,20,21,23)
LZNFQRSVDZCPTR-UHFFFAOYSA-NLZNFQRSVDZCPTR-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00899
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 6O2 →
- PDB RCSB structure 5l6h →
- UniProt UniProt P22515 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “6O2”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02344.
PDB 9
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 31
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).